University Hospitals Case Medical Center has spun off Fluence Therapeutics Inc., licensing to the company photodynamic therapy technology for the treatment of psoriasis and other skin diseases, according to MedCity News:

It’s the first time the Cleveland medical center has made a pre-seed investment in a start-up company, according to the center’s release. Fluence Therapeutics is housed at the Akron Global Business Accelerator, which is part of the city’s Biomedical Corridor District.

Cleveland attorney and entrepreneur Warren Goldenberg has become Fluence Therapeutics’ founding chief executive, said Stephen Behm, technology management director at the Center for Clinical Research and Technology UH Case Medical Center. “He has a successful track record with early stage companies,”  including CardioInsight and Imalux, that were developed at Case or University Hospitals, Behm said in the release.

Read the entire article on the MedCity News site.